FANTOM Training Event: Exploring Clinical Trials and Bioethics 2025
Fantom Training Event
Date: May21st to 23rd, 2025(training event for Fantom students)
Location:
University Medical Center Hamburg-Eppendorf, Building N21, Seminar-room 2nd floor, Martinistr. 52, 20251 Hamburg
The Bioethics and Clinical Trials workshop organised by the Universitätsklinikum Hamburg Eppendorf (UKE) expanded our knowledge of science and medicine beyond the research lab.
The FIRST DAY started with an interactive session on Diversity, Equality and Inclusion. Dr. Lima Sayed was an excellent speaker, clearly introducing concepts such as the Learning Edge and Psychological Safety; and facilitating in-depth discussions. We shared our experiences in our respective universities and lab environments, covering individual challenges as well as structural barriers.
Next, we shifted gears for a scientific lecture on single-cell RNA-seq technologies and their impact in cancer research from Flavia Watusi de Faria. From this inspiring introduction, we were excited to continue learning about single-cell approaches and the possibilities of omics-driven progress.
The final session of the day engaged us in a set of bioethical topics: organ donation and euthanasia. Our speaker, Dr. med. Beate Winkler provided unique insight into the day-to-day implications of the laws in the field and the types of decisions clinicians and families are making. It was especially enriching to hear international perspectives from everyone involved in the workshop, highlighting the diverging cultural and legal approaches to these medical concerns.
The NEXT DAY, Thursday 22nd, we tackled all things clinical trials.
Prof. Wilhelm Woessman gave us a historical perspective and a whistle-stop tour of trials in Non-Hodgkin Lymphoma. We were surprised to learn how running academic trials has evolved over the years and how some trials that defined current treatment protocols might not have been approved today.
Next, Dr. med. Till Holsten updated us on trials in Anaplastic Large Cell Lymphoma. We discussed the particular challenges faced in the paediatric space, where trial design and implementation are even more complex. Additionally, rare malignancies frequently suffer from limited trial opportunities, further complicating progress in approved treatments.
For the rest of the morning, we delved into data management in clinical trials, hearing from experienced documentalists from the Society for Paediatric Oncology and Haematology (GPOH ZDM gGmbH). This was followed by a scientifically stimulating talk from representatives of Miltenyi Biotec, who provided an industry perspective on coordinating trials and the pathway of compassionate use.
Finally, Helena Kerp wrapped up the session with a clear and insightful overview of current clinical trial regulations. She outlined how trials are structured, from design and approval to execution and reporting, emphasising the importance of Good Clinical Practice (GCP) and ethical oversight. Helena also touched on the European Clinical Trials Regulation, which aims to streamline processes and improve transparency across the EU. Her talk served as a strong reminder of the crucial role that regulation plays in ensuring both patient safety and scientific integrity.
After an intense and information-packed day, we traded the lecture hall for some fresh air and culture, wrapping up with a relaxed stroll through the city. We visited the iconic Elbphilharmonie Hamburg, soaking in the stunning views of the harbour and skyline. From there, it was off to a cosy dinner together with plenty of lively conversation and laughter.
And for those with energy still to spare—well, let’s just say the students took full advantage of Hamburg’s nightlife. Rumour has it the scientific discussions continued… on the dance floor!
Our FINAL DAY of the FANTOM meeting began with a breakdown of the people and institutions involved in clinical trial development, aimed towards providing insight into careers in clinical trial management, data management, and all other aspects involved in designing and conducting a trial.
We ended our meeting with Jason Branford, a philosopher from the Department of Informatics at the University of Hamburg, whose talk on “The promise and perils of AI in medicine” evoked serious reflections in us—a thrilling and balanced view of a changing field that is closely connected to our research activity.
We’re leaving with new knowledge, strengthened collaborations, and a shared excitement for what’s ahead.
See our LinkedIn HAMBURG VIDEO SUMMARY to soak up the atmosphere of our days in Hamburg.
Thank you to the organisers and to all the presenters for engaging discussions!
Stefania, Enrique, and Carla
From Media
